Real-World Data Of Cancer Drugs In Elderly Could Push Regulators Toward Broader Trial Eligibility

 
• By Sarah Karlin-Smith
senior citizens playing cards
Real-world evidence shows older patients not getting trial-level benefits of cancer drugs. • Source: DCPhoto / Alamy Stock Photo

More from Real-World Evidence

More from Clinical Trials